News

Working Groups Seeking Online Curriculum Consultant

10 Dec 2020
by Working Group
RFP Writer New Tools Research Literacy
New Tools Research Literacy vaccines diagnostics Drugs Online course

The Stop TB Partnership Working Group on New TB Vaccines (WGNV), Working Group on New TB Drugs (WGND), and New Diagnostics Working Group (NDWG) are developing an online course specifically designed for advocates and affected communities to provide a base of knowledge in TB research and to generate interest and engagement in TB research advocacy. The New Tools Working Groups (WGs) are seeking an online curriculum consultant/ writer for the course. The consultant will contract with the host organization for each of the WGs. 

The overall goal of this project is to develop an online curriculum that will provide participants with a basic working knowledge and understanding of issues in TB research for vaccines, drugs, and diagnostics, even with no prior knowledge and experience with TB research. The content will consist of basics aimed at advocates, individuals from affected communities and other stakeholders interested in new tool research and development. 

An RFP for the project can be found at this link. 

Proposals are due Thursday, December 31st, 2020. 

Please address your proposal and any inquiries to: 
Jennifer Woolley 
Secretariat 
Working Group on New TB Vaccines 
wgnv@newtbvaccines.org  
 

 

More News
22 Jul 2024

With NIH Funding, A New Consortium Aims to Improve TB Treatment

The National Institutes of Health’s National Institute of Allergy and Infectious Diseases (NIAID) has issued a $30.8 million grant to the Preclinical Design and Clinical Translation of TB Regimens (PreDiCTR) consortium , a new consortium co-led by investigators from Weill Cornell Medicine; the...
27 Jun 2024

WHO Released Its Updated Bacterial Priority Pathogens List

On May 17, the World Health Organization (WHO) released its updated  Bacterial Priority Pathogens List (BPPL) 2024 and for the first time in its history it included a drug resistant strain of Mycobacterium tuberculosis. Along with three other new families of antibiotic-resistant bacterial pathogens...
19 Mar 2024

Most Robust TB Drug Pipeline in History

For World TB Day 2024, the WGND is spotlighting a monumental achievement in TB drug research and development: the Global TB Drug Pipeline has never been bigger than it is today. The number of drug candidates being clinically evaluated for use in the treatment of adult pulmonary TB has surpassed...